Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Paul

Showing results (911-920 of 962) with videos related to

Pageof 97
Sort By:
BMC Health Services Research|November 22, 2017
Integrating acute stroke telemedicine consultations into specialists' usual practice: a qualitative analysis comparing the experience of Australia and the United KingdomKathleen L Bagot, Dominique A Cadilhac, Christopher F Bladin, et al.
Communications Biology|March 2, 2023
Vivid COVID-19 LAMP is an ultrasensitive, quadruplexed test using LNA-modified primers and a zinc ion and 5-Br-PAPS colorimetric detection systemAdrián Szobi, Katarína Buranovská, Nina Vojtaššáková, et al.
Redox Biology|June 6, 2024
Biliverdin Reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3βChiara Lanzillotta, Antonella Tramutola, Simona Lanzillotta, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)Donna Niedzwiecki, Wendy L Frankel, Alan P Venook, et al.
Scientific Reports|January 31, 2025
Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indicationsColin D Paul, Chris Yankaskas, Pradip Shahi Thakuri, et al.
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Scientific Reports|October 15, 2021
Surveillance of SARS-CoV-2 lineage B.1.1.7 in Slovakia using a novel, multiplexed RT-qPCR assayKristína Boršová, Evan D Paul, Viera Kováčová, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug ConjugatesEvan D Paul, Barbora Huraiová, Natália Valková, et al.
Journal of the National Cancer Institute|November 15, 2007
Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancerAlison M Hosey, Julia J Gorski, Margaret M Murray, et al.
Pageof 97

Showing results (911-920 of 962) with videos related to

Sort By:
Pageof 97
BMC Health Services Research|November 22, 2017
Integrating acute stroke telemedicine consultations into specialists' usual practice: a qualitative analysis comparing the experience of Australia and the United KingdomKathleen L Bagot, Dominique A Cadilhac, Christopher F Bladin, et al.
Communications Biology|March 2, 2023
Vivid COVID-19 LAMP is an ultrasensitive, quadruplexed test using LNA-modified primers and a zinc ion and 5-Br-PAPS colorimetric detection systemAdrián Szobi, Katarína Buranovská, Nina Vojtaššáková, et al.
Redox Biology|June 6, 2024
Biliverdin Reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3βChiara Lanzillotta, Antonella Tramutola, Simona Lanzillotta, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)Donna Niedzwiecki, Wendy L Frankel, Alan P Venook, et al.
Scientific Reports|January 31, 2025
Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indicationsColin D Paul, Chris Yankaskas, Pradip Shahi Thakuri, et al.
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Scientific Reports|October 15, 2021
Surveillance of SARS-CoV-2 lineage B.1.1.7 in Slovakia using a novel, multiplexed RT-qPCR assayKristína Boršová, Evan D Paul, Viera Kováčová, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug ConjugatesEvan D Paul, Barbora Huraiová, Natália Valková, et al.
Journal of the National Cancer Institute|November 15, 2007
Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancerAlison M Hosey, Julia J Gorski, Margaret M Murray, et al.
Pageof 97